InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ...
A federal appeals court affirmed Alabama State University’s victory over a former athletic department official’s pay ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
Second, continue to build the clinical evidence to make Vafseo standard of care for patients on dialysis; and third, execute on our impressive kidney disease-focused clinical development pipeline.
MedPage Today on MSN
What a U.S. Study Found About the Shingles Vaccine and Dementia
Analysis assessed dementia risk with the current two-dose shot ...
When my one-month-old daughter was diagnosed with biliary atresia — a rare disease that for most of human history was ...
A dead poet’s cluttered mansion is the setting for a heady brew of magic, mystery and mushrooms ...
SOUTH SAN FRANCISCO, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through ...
Steven Gyurko, a representative of Thomas Musiol, the liquidator appointed to BGS Security Ltd on 10 November 2025 by the ...
An appeal tribunal has ruled that an employment tribunal was wrong to reject a disability discrimination claim brought by a ...
Novavax ended the first quarter of 2026, with $818 million in cash and accounts receivables. We added $80 million of nondilutive cash in the first quarter of 2026, including a $30 million Pfizer ...
The FCA has published a combined consultation and discussion paper (CP26/15) on simplifying its financial promotions rules for consumer credit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results